Table of contents
September 2004 Vol 2 No 9
In This Issue
p683 | doi:10.1038/nrmicro986
Editorial: Staying ahead of the fourth horseman
p684 | doi:10.1038/nrmicro989
Research Highlights
Anti-infectives: Toxic mechanisms
p685 | doi:10.1038/nrmicro991
Anti-infectives: Targeting SARS
p686 | doi:10.1038/nrmicro985
Innate immunity: Diverse defence
p686 | doi:10.1038/nrmicro992
Bacterial physiology: Ever-decreasing circles
p687 | doi:10.1038/nrmicro993
In brief
Environmental microbiology | Bacterial toxins | Environmental microbiology
p687 | doi:10.1038/nrmicro994
Infectious disease: Partners in crime
p688 | doi:10.1038/nrmicro983
Bacterial pathogenicity: A sticky situation
p688 | doi:10.1038/nrmicro984
Malaria: Joint attack on malaria
p689 | doi:10.1038/nrmicro990
News and Analysis
Disease watch
Focus: Leishmaniasis
p692 | doi:10.1038/nrmicro981
Disease watch
Self-help for malaria in chimps | China gets TB under control | Network to fight bird flu | Award for Hiroshi Nikaido | Outbreak news: update for September
p692 | doi:10.1038/nrmicro988
Focus on: Antimicrobial Strategies
Reviews
Passive antibody therapy for infectious diseases
Arturo Casadevall, Ekaterina Dadachova & Liise-anne Pirofski
p695 | doi:10.1038/nrmicro974
Antivirals and antiviral strategies
Erik De Clercq
p704 | doi:10.1038/nrmicro975
Antitoxins: novel strategies to target agents of bioterrorism
G. Jonah A. Rainey & John A. T. Young
p721 | doi:10.1038/nrmicro977
Primate defensins
Robert I. Lehrer
p727 | doi:10.1038/nrmicro976
Perspective
Seeing is believing: the impact of structural genomics on antimicrobial drug discovery
Molly B. Schmid
p739 | doi:10.1038/nrmicro978
Review
Persistent bacterial infections: the interface of the pathogen and the host immune system
Denise M. Monack, Anne Mueller & Stanley Falkow
p747 | doi:10.1038/nrmicro955
Natureview: Reviews and comment from the nature publishing group
p766 | doi:10.1038/nrmicro987
